Thus, although RSPO fusions have been identified in prostate cancer patients and several reports have implicated RSPOs in prostate carcinogenesis, some controversy exists on the contribution of RSPOs to prostate cancer development. This evidence concerns the gene RSPO1 and prostate cancer.